1. Home
  2. LMNR vs PRLD Comparison

LMNR vs PRLD Comparison

Compare LMNR & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limoneira Co

LMNR

Limoneira Co

HOLD

Current Price

$13.25

Market Cap

256.6M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$3.14

Market Cap

207.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMNR
PRLD
Founded
1893
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
256.6M
207.5M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
LMNR
PRLD
Price
$13.25
$3.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$20.00
$4.67
AVG Volume (30 Days)
52.5K
316.0K
Earning Date
06-15-2026
06-17-2026
Dividend Yield
2.25%
N/A
EPS Growth
N/A
23.21
EPS
N/A
N/A
Revenue
$159,723,000.00
$12,140,000.00
Revenue This Year
N/A
$320.10
Revenue Next Year
$14.86
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
73.43
52 Week Low
$12.20
$0.61
52 Week High
$18.40
$4.19

Technical Indicators

Market Signals
Indicator
LMNR
PRLD
Relative Strength Index (RSI) 38.04 54.67
Support Level $12.69 $1.02
Resistance Level $15.13 $4.10
Average True Range (ATR) 0.42 0.33
MACD -0.09 -0.00
Stochastic Oscillator 27.20 41.78

Price Performance

Historical Comparison
LMNR
PRLD

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: